01 10Keytruda
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 14,380
2019 Revenue in Millions : 11,084
Growth (%) : 30
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 17,186
2020 Revenue in Millions : 14,380
Growth (%) : 20
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 20,937
2021 Revenue in Millions : 17,186
Growth (%) : 22
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 25,011
2022 Revenue in Millions : 20,937
Growth (%) : 19
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 55
2014 Revenue in Millions : 566
Growth (%) : 929%
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions :
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 1,402
2015 Revenue in Millions : 566
Growth (%) : 148
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 3,809
2016 Revenue in Millions : 1,402
Growth (%) : 172
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 7,171
2017 Revenue in Millions : 3,809
Growth (%) : 88%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 11,084
2018 Revenue in Millions : 7,171
Growth (%) : 55
LOOKING FOR A SUPPLIER?
